(Q40060499)

17 September 2017

Downregulation of CCN3 expression as a potential mechanism for melanoma progression (English)

1 reference

17 September 2017

M Fukunaga-Kalabis

1

1 reference

17 September 2017

G Martinez

2

1 reference

17 September 2017

S M Telson

3

1 reference

17 September 2017

Z-J Liu

4

1 reference

17 September 2017

K Balint

5

1 reference

17 September 2017

I Juhasz

6

1 reference

17 September 2017

D E Elder

7

1 reference

17 September 2017

B Perbal

8

1 reference

17 September 2017

M Herlyn

9

1 reference

17 September 2017

language of work or name

English

0 references

publication date

29 October 2007

1 reference

17 September 2017

1 reference

17 September 2017

27

1 reference

17 September 2017

2552-2560

1 reference

17 September 2017

18

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210896

17 September 2017

0 references

cites work

In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210896

Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210896

Tumour progression and the nature of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210896

An inhibitor of stress-activated MAP-kinases reduces invasion and MMP-2 expression of malignant melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210896

CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210896

Patterns of specific genomic alterations associated with poor prognosis in high-grade renal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210896

Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210896

The role of altered cell-cell communication in melanoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210896

Adhesion, migration and communication in melanocytes and melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210896

Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210896

Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210896

Tenascin-C upregulates matrix metalloproteinase-9 in breast cancer cells: direct and synergistic effects with transforming growth factor beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210896

WISP3 (CCN6) is a secreted tumor-suppressor protein that modulates IGF signaling in inflammatory breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210896

Integrin signaling in malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210896

CCN5 is a growth arrest-specific gene that regulates smooth muscle cell proliferation and motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210896

Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210896

The expression of ccn3(nov) gene in musculoskeletal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210896

Epidermal stem cells do not communicate through gap junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210896

A novel mechanism for BCR-ABL action: stimulated secretion of CCN3 is involved in growth and differentiation regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210896

Tumor-derived Cyr61(CCN1) promotes stromal matrix metalloproteinase-1 production and protease-activated receptor 1-dependent migration of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210896

NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210896

Report on the second international workshop on the CCN family of genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210896

Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210896

Nuclear addressing provides a clue for the transforming activity of amino-truncated CCN3 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210896

SPARC represses E-cadherin and induces mesenchymal transition during melanoma development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210896

Molecular role(s) for integrins in human melanoma invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210896

Specific blockade of the ERK pathway inhibits the invasiveness of tumor cells: down-regulation of matrix metalloproteinase-3/-9/-14 and CD44

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210896

Osteopontin expression correlates with melanoma invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210896

NOVH increases MMP3 expression and cell migration in glioblastoma cells via a PDGFR‐α‐dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210896

inferred from DOI database lookup

7 January 2021

based on heuristic

Osteonectin expression correlates with clinical outcome in thin cutaneous malignant melanomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210896

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1210896

1 reference

Dimensions Publication ID

17 September 2017

0 references

1 reference